Cargando…

Surrogate endpoints in global health research: still searching for killer apps and silver bullets?

Detalles Bibliográficos
Autores principales:	Pai, Madhukar, Schumacher, Samuel G, Abimbola, Seye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873542/ https://www.ncbi.nlm.nih.gov/pubmed/29607104 http://dx.doi.org/10.1136/bmjgh-2018-000755

Ejemplares similares

Global health degrees: at what cost?
por: Svadzian, Anita, et al.
Publicado: (2020)

Surrogate endpoints.
por: Ellenberg, S. S.
Publicado: (1993)

The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project
por: Sargent, Daniel J., et al.
Publicado: (2017)

Funders: The missing link in equitable global health research?
por: Charani, Esmita, et al.
Publicado: (2022)

The evaluation of surrogate endpoints
por: Burzykowski, Tomasz, et al.
Publicado: (2005)

Surrogate Endpoints in Medicine
por: Srivastava, Sudhir, et al.
Publicado: (2002)

Surrogate endpoints in early prostate cancer research
por: Williams, Scott
Publicado: (2018)

Is Silver the Ultimate Antimicrobial Bullet?
por: Turner, Raymond J
Publicado: (2018)

Dupilumab for Atopic Dermatitis: The Silver Bullet We Have Been Searching for?
por: Tameez Ud Din, Ahsan, et al.
Publicado: (2020)

How we classify countries and people—and why it matters
por: Khan, Themrise, et al.
Publicado: (2022)

Searching for potential surrogate endpoints of overall survival in clinical trials for patients with prostate cancer
por: Maeda, Hideki, et al.
Publicado: (2021)

Surrogate endpoints and competing risk of death in cardiac arrest research
por: McCredie, Victoria A., et al.
Publicado: (2016)

Overview of Biomarkers and Surrogate Endpoints in Drug Development
por: Wagner, John A.
Publicado: (2002)

Is critical care ready for an economic surrogate endpoint?
por: Wilcox, M Elizabeth, et al.
Publicado: (2015)

Surrogate endpoints… Uncommon for a common man!
por: Kumar, Ashish
Publicado: (2019)

Surrogate Endpoints for Late Kidney Transplantation Failure
por: Naesens, Maarten, et al.
Publicado: (2022)

The information problem in global health
por: Abimbola, Seye
Publicado: (2016)

The uses of knowledge in global health
por: Abimbola, Seye
Publicado: (2021)

Need for better reporting of trials with surrogate endpoints: SPIRIT|CONSORT-SURROGATE extensions
por: Ciani, Oriana, et al.
Publicado: (2022)

The challenges of defining global health research
por: Garcia-Basteiro, Alberto L, et al.
Publicado: (2021)

Stray bullet: An accidental killer during riot control
por: Wani, Abrar A., et al.
Publicado: (2011)

The foreign gaze: authorship in academic global health
por: Abimbola, Seye
Publicado: (2019)

A priori registration of global health research—necessity or absurdity?
por: Eboreime, Ejemai Amaize, et al.
Publicado: (2021)

Arginine methylation: the promise of a ‘silver bullet’ for brain tumours?
por: Samuel, Sabrina F., et al.
Publicado: (2021)

Heparin: The Silver Bullet of Aneurysmal Subarachnoid Hemorrhage?
por: Khattar, Nicolas K., et al.
Publicado: (2018)

Statistical evaluation of surrogate endpoints: a systematic review
por: Ensor, Hannah, et al.
Publicado: (2013)

Bivariate network meta‐analysis for surrogate endpoint evaluation
por: Bujkiewicz, Sylwia, et al.
Publicado: (2019)

Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma
por: Medeiros, Felipe A.
Publicado: (2017)

Surrogate endpoints in trials: a call for better reporting
por: Ciani, Oriana, et al.
Publicado: (2022)

Surrogate endpoint evaluation using data from one large global randomized controlled trial
por: Geybels, Milan, et al.
Publicado: (2021)

Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE
por: Manyara, Anthony Muchai, et al.
Publicado: (2022)

How to run successful projects II: the silver bullet
por: O'Connell, Fergus
Publicado: (1994)

How to run successful project III: the silver bullet
por: O'Connell, Fergus, et al.
Publicado: (2001)

Polishing the tarnished silver bullet: the quest for new antibiotics
por: Blaskovich, Mark A.T., et al.
Publicado: (2017)

Diet-derived microRNAs: unicorn or silver bullet?
por: Witwer, Kenneth W., et al.
Publicado: (2017)

Radiation Biomarkers: Silver Bullet, or Wild Goose Chase?
por: Rutten, Eric Andreas, et al.
Publicado: (2021)

No silver bullet: interpretable ML models must be explained
por: Marques-Silva, Joao, et al.
Publicado: (2023)

Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria
por: Jeeyapant, Atthanee, et al.
Publicado: (2017)

Uncertainty in the Bayesian meta-analysis of normally distributed surrogate endpoints
por: Bujkiewicz, Sylwia, et al.
Publicado: (2015)

Surrogate endpoints in advanced sarcoma trials: a meta-analysis
por: Savina, Marion, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o43r32j6igl20qn0g3cp37gfob